Blood Journal
Leading the way in experimental and clinical research in hematology

Redirected tumor-specific allogeneic T cells for universal treatment of cancer

  1. Assaf Marcus,
  2. Tova Waks, and
  3. Zelig Eshhar*
  1. 1 Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
  1. * Corresponding author; email: zelig.eshhar{at}
PDF Container